1084 related articles for article (PubMed ID: 31939999)
1. Core Outcome Set for Actinic Keratosis Clinical Trials.
Reynolds KA; Schlessinger DI; Vasic J; Iyengar S; Qaseem Y; Behshad R; DeHoratius DM; Denes P; Drucker AM; Dzubow LM; Etzkorn JR; Harwood C; Kim JYS; Lee EH; Lissner GS; Marghoob AA; Matin RN; Mattox A; Mittal BB; Thomas JR; Zhou XA; Zloty D; Schmitt J; Kirkham J; Poon E; Sobanko JF; Cartee TV; Maher IA; Alam M
JAMA Dermatol; 2020 Mar; 156(3):326-333. PubMed ID: 31939999
[TBL] [Abstract][Full Text] [Related]
2. Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set.
Heppt MV; Steeb T; Schmitz L; Garbe C; French LE; Leiter U; Berking C
Trials; 2019 Oct; 20(1):589. PubMed ID: 31604473
[TBL] [Abstract][Full Text] [Related]
3. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
[TBL] [Abstract][Full Text] [Related]
4. Core outcome set for studies investigating management of selective fetal growth restriction in twins.
Townsend R; Duffy JMN; Sileo F; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ; Khalil A;
Ultrasound Obstet Gynecol; 2020 May; 55(5):652-660. PubMed ID: 31273879
[TBL] [Abstract][Full Text] [Related]
5. Core outcome set for research studies evaluating treatments for twin-twin transfusion syndrome.
Perry H; Duffy JMN; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D; Khalil A;
Ultrasound Obstet Gynecol; 2019 Aug; 54(2):255-261. PubMed ID: 30520170
[TBL] [Abstract][Full Text] [Related]
6. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
[TBL] [Abstract][Full Text] [Related]
7. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
8. Prioritization of Outcomes in Efficacy and Effectiveness of Alcohol Brief Intervention Trials: International Multi-Stakeholder e-Delphi Consensus Study to Inform a Core Outcome Set.
Shorter GW; Heather N; Bray JW; Berman AH; Giles EL; O'Donnell AJ; Barbosa C; Clarke M; Holloway A; Newbury-Birch D
J Stud Alcohol Drugs; 2019 May; 80(3):299-309. PubMed ID: 31250794
[TBL] [Abstract][Full Text] [Related]
9. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.
Callis Duffin K; Merola JF; Christensen R; Latella J; Garg A; Gottlieb AB; Armstrong AW
JAMA Dermatol; 2018 Oct; 154(10):1137-1144. PubMed ID: 29874367
[TBL] [Abstract][Full Text] [Related]
10. Influence of Information Framing on Patient Decisions to Treat Actinic Keratosis.
Berry K; Butt M; Kirby JS
JAMA Dermatol; 2017 May; 153(5):421-426. PubMed ID: 28114674
[TBL] [Abstract][Full Text] [Related]
11. Three nested randomized controlled trials of peer-only or multiple stakeholder group feedback within Delphi surveys during core outcome and information set development.
Brookes ST; Macefield RC; Williamson PR; McNair AG; Potter S; Blencowe NS; Strong S; Blazeby JM
Trials; 2016 Aug; 17(1):409. PubMed ID: 27534622
[TBL] [Abstract][Full Text] [Related]
12. Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.
Sanz M; Carrillo de Albornoz A; Martín C; Needleman I; Tonetti MS
J Clin Periodontol; 2023 May; 50 Suppl 25():107-121. PubMed ID: 37143293
[TBL] [Abstract][Full Text] [Related]
13. Multi-stakeholder contribution to the identification of a core outcome set and measurements in implant dentistry (ID-COSM initiative) using the Delphi methodology.
Sanz M; Carrillo de Albornoz A; Martín C; Needleman I; Tonetti MS
Clin Oral Implants Res; 2023 May; 34 Suppl 25():108-120. PubMed ID: 37232119
[TBL] [Abstract][Full Text] [Related]
14. Development of a core outcome set and outcome definitions for studies on uterus-sparing treatments of adenomyosis (COSAR): an international multistakeholder-modified Delphi consensus study.
Tellum T; Naftalin J; Chapron C; Dueholm M; Guo SW; Hirsch M; Larby ER; Munro MG; Saridogan E; van der Spuy ZM; Jurkovic D
Hum Reprod; 2022 Aug; 37(9):2012-2031. PubMed ID: 35906919
[TBL] [Abstract][Full Text] [Related]
15. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
Trials; 2020 May; 21(1):437. PubMed ID: 32460828
[TBL] [Abstract][Full Text] [Related]
16. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
[TBL] [Abstract][Full Text] [Related]
17. Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines.
Christensen RE; Elston DM; Worley B; Dirr MA; Anvery N; Kang BY; Bahrami S; Brodell RT; Cerroni L; Elston C; Ferringer T; Hurley MY; Garton K; Lee JSS; Liu Y; Maize JC; McNiff JM; Rapini RP; Sangueza OP; Shea CR; Zhou C; Alam M
J Am Acad Dermatol; 2023 Jun; 88(6):1317-1325. PubMed ID: 36841336
[TBL] [Abstract][Full Text] [Related]
18. Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Iyengar S; Williamson PR; Schmitt J; Johannsen L; Maher IA; Sobanko JF; Cartee TV; Schlessinger D; Poon E; Alam M
Trials; 2016 Sep; 17(1):429. PubMed ID: 27580586
[TBL] [Abstract][Full Text] [Related]
19. European Society of Coloproctology Core Outcome Set for haemorrhoidal disease: an international Delphi study among healthcare professionals.
van Tol RR; Kimman ML; Melenhorst J; Stassen LPS; Dirksen CD; Breukink SO;
Colorectal Dis; 2019 May; 21(5):570-580. PubMed ID: 30628177
[TBL] [Abstract][Full Text] [Related]
20. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study.
Whitham D; Turzanski J; Bradshaw L; Clarke M; Culliford L; Duley L; Shaw L; Skea Z; Treweek SP; Walker K; Williamson PR; Montgomery AA;
Trials; 2018 Oct; 19(1):557. PubMed ID: 30326967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
